Galectin-3 Deficiency Accelerates High-Fat Diet–Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets

Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet–induced obesity and diabetes. Obese LGALS3−/− mice have increased body weig...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) Jg. 62; H. 6; S. 1932 - 1944
Hauptverfasser: Pejnovic, Nada N., Pantic, Jelena M., Jovanovic, Ivan P., Radosavljevic, Gordana D., Milovanovic, Marija Z., Nikolic, Ivana G., Zdravkovic, Nemanja S., Djukic, Aleksandar L., Arsenijevic, Nebojsa N., Lukic, Miodrag L.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Alexandria, VA American Diabetes Association 01.06.2013
Schlagworte:
ISSN:0012-1797, 1939-327X, 1939-327X
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet–induced obesity and diabetes. Obese LGALS3−/− mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3−/− mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c+CD11b+ macrophages and decreased CD4+CD25+FoxP3+ regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3−/− animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3−/− peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1–dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3−/− macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
AbstractList Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3(-/-) mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3(-/-) mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c(+)CD11b(+) macrophages and decreased CD4(+)CD25(+)FoxP3(+) regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1[beta] (IL-1[beta]) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3(-/-) animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3(-/-) peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1[beta] production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3(-/-) macrophages with NLRP3 small interfering RNA attenuated IL-1[beta] production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese [LGALS3.sup.-/-] mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese [LGALS3.sup.-/-] mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory [CD11c.sup.+][CD11b.sup.+] macrophages and decreased [CD4.sup.+][CD25.sup.+][FoxP3.sup.+] regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1[beta] (IL-1[beta]) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese [LGALS3.sup.-/-] animals accompanied with elevated phosphorylated nuclear factor-[kappa]B (NF-[kappa]B) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of [LGALS3.sup.-/-] peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1[beta] production and increased phosphorylation of NF-[kappa]B p65 compared with WT cells. Transfection of [LGALS3.sup.-/-] macrophages with NLRP3 small interfering RNA attenuated IL-1[beta] production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet–induced obesity and diabetes. Obese LGALS3−/− mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3−/− mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c+CD11b+ macrophages and decreased CD4+CD25+FoxP3+ regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3−/− animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3−/− peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1–dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3−/− macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3(-/-) mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3(-/-) mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c(+)CD11b(+) macrophages and decreased CD4(+)CD25(+)FoxP3(+) regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3(-/-) animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3(-/-) peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3(-/-) macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3(-/-) mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3(-/-) mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c(+)CD11b(+) macrophages and decreased CD4(+)CD25(+)FoxP3(+) regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3(-/-) animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3(-/-) peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3(-/-) macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese [LGALS3.sup.-/-] mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese [LGALS3.sup.-/-] mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory [CD11c.sup.+][CD11b.sup.+] macrophages and decreased [CD4.sup.+][CD25.sup.+][FoxP3.sup.+] regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese [LGALS3.sup.-/-] animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of [LGALS3.sup.-/-] peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of [LGALS3.sup.-/-] macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3 (Gal-3), a galactoside-binding lectin, accelerates high-fat diet-induced obesity and diabetes. Obese LGALS3(-/-) mice have increased body weight, amount of total visceral adipose tissue (VAT), fasting blood glucose and insulin levels, homeostasis model assessment of insulin resistance, and markers of systemic inflammation compared with diet-matched wild-type (WT) animals. VAT of obese LGALS3(-/-) mice exhibited increased incidence of type 1 T and NKT lymphocytes and proinflammatory CD11c(+)CD11b(+) macrophages and decreased CD4(+)CD25(+)FoxP3(+) regulatory T cells and M2 macrophages. Pronounced mononuclear cell infiltrate, increased expression of NLRP3 inflammasome and interleukin-1β (IL-1β) in macrophages, and increased accumulation of advanced glycation end products (AGEs) and receptor for AGE (RAGE) expression were present in pancreatic islets of obese LGALS3(-/-) animals accompanied with elevated phosphorylated nuclear factor-κB (NF-κB) p65 and mature caspase-1 protein expression in pancreatic tissue and VAT. In vitro stimulation of LGALS3(-/-) peritoneal macrophages with lipopolysaccharide (LPS) and saturated fatty acid palmitate caused increased caspase-1-dependent IL-1β production and increased phosphorylation of NF-κB p65 compared with WT cells. Transfection of LGALS3(-/-) macrophages with NLRP3 small interfering RNA attenuated IL-1β production in response to palmitate and LPS plus palmitate. Obtained results suggest important protective roles for Gal-3 in obesity-induced inflammation and diabetes.
Audience Professional
Author Djukic, Aleksandar L.
Pejnovic, Nada N.
Lukic, Miodrag L.
Milovanovic, Marija Z.
Arsenijevic, Nebojsa N.
Nikolic, Ivana G.
Pantic, Jelena M.
Jovanovic, Ivan P.
Radosavljevic, Gordana D.
Zdravkovic, Nemanja S.
Author_xml – sequence: 1
  givenname: Nada N.
  surname: Pejnovic
  fullname: Pejnovic, Nada N.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia, Institute of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
– sequence: 2
  givenname: Jelena M.
  surname: Pantic
  fullname: Pantic, Jelena M.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 3
  givenname: Ivan P.
  surname: Jovanovic
  fullname: Jovanovic, Ivan P.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 4
  givenname: Gordana D.
  surname: Radosavljevic
  fullname: Radosavljevic, Gordana D.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 5
  givenname: Marija Z.
  surname: Milovanovic
  fullname: Milovanovic, Marija Z.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 6
  givenname: Ivana G.
  surname: Nikolic
  fullname: Nikolic, Ivana G.
  organization: Department of Immunology, Institute for Biological Research “Sinisa Stankovic,” University of Belgrade, Belgrade, Serbia
– sequence: 7
  givenname: Nemanja S.
  surname: Zdravkovic
  fullname: Zdravkovic, Nemanja S.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 8
  givenname: Aleksandar L.
  surname: Djukic
  fullname: Djukic, Aleksandar L.
  organization: Institute of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia, Center for Endocrinology, Diabetes, and Metabolic Diseases, Clinical Center Kragujevac, Kragujevac, Serbia
– sequence: 9
  givenname: Nebojsa N.
  surname: Arsenijevic
  fullname: Arsenijevic, Nebojsa N.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
– sequence: 10
  givenname: Miodrag L.
  surname: Lukic
  fullname: Lukic, Miodrag L.
  organization: Center for Molecular Medicine and Stem Cell Research, Kragujevac, Serbia
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27485202$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23349493$$D View this record in MEDLINE/PubMed
BookMark eNp9k01v0zAYxyM0xLrBgS-AIiEkOGTzW5zkglR1rKtUqRyGxM1ynMedJ8cpsYPojQPfgG_IJ8HdupVChXywZP_-_8fPi0-SI9c5SJKXGJ0RSovzpsYkQ4SQJ8kIV7TKKCk-HyUjhOI5LqriODnx_hYhxON6lhxHFatYRUfJj6m0oIJxGU0vQBtlwKl1OlYKLPQygE-vzPImu5QhvTAQfn3_OXPNoKBJFzV4E9apdE06blfWaBPpmdNWtq0MpnOpcem4MavOQ3ptvB_gDv4oneohEiqdeQvBP0-eamk9vNjup8mnyw_Xk6tsvpjOJuN5pnjBQ8ZKjrVGjaJcopoAZ5g1HJdSq7JqMIZcVTWpGMvrRoNmFc5xndecylJGAaKnyft739VQt9AocKGXVqx608p-LTppxP6NMzdi2X0VlHPMMY4Gb7cGffdlAB9Ea3yslJUOusELTPOclQgzHtHXf6G33dC7mJ7AjHCUFwjRHbWMbRDG6S7GVRtTMaaU8DzPi03Y7AC1BBc7ZOMoaBOP9_izA3xcDbRGHRS82xNEJsC3sJSD96Kczv_3mC2rOmthCSI2bLLY51_9WfTHaj_MYATebAHplbS6j-Nh_I4rWJkTRCJ3fs-pvvO-By2UCXdzFrMzVmC08SzE5jeIzW_YpfWoeDD9l_0NimoG5g
CODEN DIAEAZ
CitedBy_id crossref_primary_10_1161_JAHA_115_002347
crossref_primary_10_1161_CIRCGEN_123_004192
crossref_primary_10_3390_nu15214574
crossref_primary_10_1111_aji_13311
crossref_primary_10_3748_wjg_v22_i44_9706
crossref_primary_10_3748_wjg_v25_i43_6465
crossref_primary_10_2478_sjecr_2022_0008
crossref_primary_10_1016_j_intimp_2015_01_003
crossref_primary_10_3390_ijms21228580
crossref_primary_10_3389_fcell_2019_00310
crossref_primary_10_1002_kjm2_12890
crossref_primary_10_1016_j_lfs_2019_116577
crossref_primary_10_1186_s12933_015_0230_3
crossref_primary_10_1038_s41598_020_76952_z
crossref_primary_10_3390_cells13090763
crossref_primary_10_1038_s41598_021_98227_x
crossref_primary_10_1007_s10735_020_09898_1
crossref_primary_10_1007_s11325_023_02842_z
crossref_primary_10_1038_nrd_2015_3
crossref_primary_10_1155_2018_4507659
crossref_primary_10_1007_s12565_016_0366_6
crossref_primary_10_1016_j_imlet_2017_10_010
crossref_primary_10_3390_jcm11216521
crossref_primary_10_3390_nu16010159
crossref_primary_10_1038_s41598_020_71109_4
crossref_primary_10_1155_2017_8162421
crossref_primary_10_1016_j_mad_2025_112086
crossref_primary_10_3390_nu14020332
crossref_primary_10_1096_fj_202000970RR
crossref_primary_10_1096_fj_201900125RR
crossref_primary_10_3389_fpsyt_2018_00271
crossref_primary_10_3390_jcm14176071
crossref_primary_10_1007_s40200_024_01461_z
crossref_primary_10_1038_ijo_2016_19
crossref_primary_10_1016_j_joen_2014_11_017
crossref_primary_10_1080_19382014_2017_1405189
crossref_primary_10_1096_fj_201802802RRR
crossref_primary_10_1007_s40618_014_0222_2
crossref_primary_10_1016_j_sleep_2022_09_018
crossref_primary_10_1186_1758_5996_6_106
crossref_primary_10_1038_s41598_019_50103_5
crossref_primary_10_3389_fonc_2020_00745
crossref_primary_10_1371_journal_pone_0134089
crossref_primary_10_1186_s12967_019_02191_0
crossref_primary_10_1159_000515117
crossref_primary_10_1007_s00125_013_3101_z
crossref_primary_10_1002_oby_24363
crossref_primary_10_1016_j_numecd_2022_03_001
crossref_primary_10_3390_nu9040385
crossref_primary_10_1515_cclm_2014_0187
crossref_primary_10_1016_j_cyto_2014_06_016
crossref_primary_10_1111_jnc_15166
crossref_primary_10_1038_srep12214
crossref_primary_10_1038_srep23348
crossref_primary_10_1210_jc_2019_00398
crossref_primary_10_3390_biom9050193
crossref_primary_10_1016_j_lfs_2023_122285
crossref_primary_10_1038_s41598_019_48291_1
crossref_primary_10_1016_j_jtemb_2015_02_003
crossref_primary_10_1186_s12864_019_5891_y
crossref_primary_10_1161_JAHA_123_031607
crossref_primary_10_1186_1471_2407_14_522
crossref_primary_10_3389_fendo_2020_00030
crossref_primary_10_1093_ecco_jcc_jjw013
crossref_primary_10_1186_s12868_018_0428_x
crossref_primary_10_2478_sjecr_2019_0045
crossref_primary_10_1016_j_fct_2014_04_033
crossref_primary_10_3390_ijms19020379
crossref_primary_10_3390_ijms26136101
crossref_primary_10_3389_fphys_2025_1455434
crossref_primary_10_1007_s40618_013_0032_y
crossref_primary_10_1038_bjc_2015_212
crossref_primary_10_1038_nmeth_4298
crossref_primary_10_1152_ajpendo_00461_2017
crossref_primary_10_1002_jbm_a_36535
crossref_primary_10_1016_j_arcmed_2025_103300
crossref_primary_10_1016_j_coph_2013_04_008
crossref_primary_10_1002_hep_27141
crossref_primary_10_1007_s11892_016_0782_y
crossref_primary_10_1515_sjecr_2016_0011
crossref_primary_10_1016_j_jcms_2014_01_035
crossref_primary_10_1139_cjpp_2019_0708
crossref_primary_10_1016_j_numecd_2021_03_002
crossref_primary_10_1093_glycob_cwu111
crossref_primary_10_1515_sjecr_2017_0022
crossref_primary_10_3389_fcell_2021_790568
crossref_primary_10_1177_1559827617708991
crossref_primary_10_3390_ijms221910391
crossref_primary_10_1002_advs_202103719
crossref_primary_10_1074_jbc_M116_715748
crossref_primary_10_2119_molmed_2014_00178
crossref_primary_10_1038_s41467_024_47959_1
crossref_primary_10_1084_jem_20220017
crossref_primary_10_3390_ijms160714441
crossref_primary_10_1002_med_21654
crossref_primary_10_3390_ijms20143460
crossref_primary_10_1161_CIRCULATIONAHA_121_056663
crossref_primary_10_1016_j_dsx_2019_01_018
crossref_primary_10_1016_j_lfs_2019_116882
crossref_primary_10_1016_j_bbrc_2015_06_114
crossref_primary_10_1016_j_jcms_2017_02_023
crossref_primary_10_1016_j_cell_2016_10_025
crossref_primary_10_1016_j_neurot_2025_e00744
crossref_primary_10_1242_dmm_032086
crossref_primary_10_1155_2020_5284728
crossref_primary_10_1038_s41467_022_35334_x
crossref_primary_10_1186_s10020_023_00707_5
crossref_primary_10_1155_2016_9618092
crossref_primary_10_1155_2022_1865736
crossref_primary_10_1016_j_yexcr_2018_02_030
crossref_primary_10_1038_ijo_2015_74
crossref_primary_10_3389_fphar_2021_638258
crossref_primary_10_1016_j_oraloncology_2015_11_001
crossref_primary_10_1007_s00335_021_09869_1
crossref_primary_10_3390_cimb47050332
crossref_primary_10_1089_ars_2014_6126
crossref_primary_10_3389_fimmu_2018_02646
crossref_primary_10_1155_2016_9137629
crossref_primary_10_1007_s00784_017_2123_1
crossref_primary_10_3390_cells9081812
crossref_primary_10_3389_fendo_2022_805837
crossref_primary_10_1016_j_molmed_2024_11_006
crossref_primary_10_1016_j_jash_2017_07_009
crossref_primary_10_1016_j_ijbiomac_2019_09_118
Cites_doi 10.2337/db07-1403
10.2337/db09-0287
10.4049/jimmunol.182.2.1167
10.1002/eji.200737986
10.1038/icb.2011.89
10.2337/db08-1261
10.1038/oby.2010.1
10.1073/pnas.0908771107
10.1189/jlb.0711361
10.1073/pnas.1100255108
10.1074/jbc.M301598200
10.1016/j.atherosclerosis.2009.05.004
10.1096/fj.04-2031fje
10.1038/nm.2279
10.4049/jimmunol.180.4.2650
10.1172/JCI200319451
10.1038/ncpendmet0786
10.1007/BF03216222
10.4049/jimmunol.181.4.2781
10.1038/nm.1964
10.1126/science.1184003
10.1096/fj.01-0006com
10.1038/nri2925
10.1111/j.1600-065X.2009.00798.x
10.1172/JCI29881
10.1007/BF00280883
10.1152/physiolgenomics.00035.2011
10.1016/j.bbrc.2006.03.105
10.1038/nm.2002
10.1172/JCI200319246
10.1161/01.RES.0000160543.84254.f1
10.1073/pnas.0903497106
10.1074/jbc.M706762200
10.1172/JCI57132
10.1038/ni.2022
10.1016/j.clim.2008.08.024
10.1016/j.febslet.2012.02.045
10.2337/diabetes.55.03.06.db05-0677
10.1006/bbrc.2001.4256
10.1007/s10585-011-9383-y
10.1097/MED.0b013e32833bf6dc
10.1161/ATVBAHA.109.186791
10.1161/ATVBAHA.109.198614
10.1111/j.1365-2567.2007.02724.x
ContentType Journal Article
Copyright 2014 INIST-CNRS
COPYRIGHT 2013 American Diabetes Association
COPYRIGHT 2013 American Diabetes Association
Copyright American Diabetes Association Jun 2013
2013 by the American Diabetes Association. 2013
Copyright_xml – notice: 2014 INIST-CNRS
– notice: COPYRIGHT 2013 American Diabetes Association
– notice: COPYRIGHT 2013 American Diabetes Association
– notice: Copyright American Diabetes Association Jun 2013
– notice: 2013 by the American Diabetes Association. 2013
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
3V.
7RV
7X7
7XB
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M1P
M2O
M2P
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
5PM
DOI 10.2337/db12-0222
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
STEM Database
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest AP Science
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
ProQuest Science Journals
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Research Library Prep


MEDLINE - Academic

MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 1944
ExternalDocumentID PMC3661611
3048635351
A332655571
23349493
27485202
10_2337_db12_0222
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.XZ
08P
0R~
18M
29F
2WC
354
4.4
53G
5GY
5RE
5RS
5VS
6PF
7RV
7X7
88E
88I
8AF
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8GL
8R4
8R5
AAFWJ
AAKAS
AAQQT
AAWTL
AAYEP
AAYXX
ABOCM
ABUWG
ACGFO
ACGOD
ACPRK
ADBBV
ADZCM
AEGXH
AENEX
AERZD
AFFHD
AFKRA
AHMBA
AIAGR
AIZAD
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBNVY
BCU
BEC
BENPR
BES
BHPHI
BKEYQ
BKNYI
BPHCQ
BTFSW
BVXVI
CCPQU
CITATION
CS3
DIK
DU5
DWQXO
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FRP
FYUFA
GICCO
GNUQQ
GUQSH
GX1
H13
HCIFZ
HMCUK
HZ~
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
ITC
K-O
K2M
K9-
KQ8
L7B
LK8
M0R
M1P
M2O
M2P
M2Q
M5~
M7P
NAPCQ
O5R
O5S
O9-
OB3
OHH
OK1
OVD
P2P
PCD
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RHI
RPM
S0X
SJFOW
SJN
SV3
TDI
TEORI
TR2
UKHRP
VVN
W8F
WH7
WOQ
WOW
X7M
YFH
YHG
YOC
ZY1
~KM
.GJ
1CY
8F7
AAYJJ
AAYOK
AFFNX
AI.
ALIPV
BCR
BLC
C1A
H~9
IQODW
J5H
MVM
N4W
PEA
VH1
XOL
YQJ
ZGI
ZXP
ADGHP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c676t-4861ff0dc36a0b2e6414d618afc89d11e5c9b29445bdfef49151b5b63a8aa0b03
IEDL.DBID M2P
ISICitedReferencesCount 135
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000319845000023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0012-1797
1939-327X
IngestDate Tue Nov 04 02:03:20 EST 2025
Fri Sep 05 07:52:40 EDT 2025
Mon Oct 06 18:02:22 EDT 2025
Tue Nov 11 07:38:49 EST 2025
Sat Nov 29 11:11:02 EST 2025
Tue Nov 04 17:29:39 EST 2025
Thu Nov 13 14:42:41 EST 2025
Sat Nov 29 09:36:21 EST 2025
Mon Jul 21 06:03:21 EDT 2025
Wed Apr 02 07:15:05 EDT 2025
Tue Nov 18 22:26:23 EST 2025
Sat Nov 29 04:30:40 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Endocrinopathy
Obesity
Adipose tissue
Diet
Diabetes mellitus
Deficiency
Nutrition disorder
Inflammation
Pancreas
Nutritional status
Feeding
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c676t-4861ff0dc36a0b2e6414d618afc89d11e5c9b29445bdfef49151b5b63a8aa0b03
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Feature-3
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
N.N.P. and J.M.P. contributed equally to this study.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3661611
PMID 23349493
PQID 1426057003
PQPubID 34443
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3661611
proquest_miscellaneous_1355480146
proquest_journals_1426057003
gale_infotracmisc_A332655571
gale_infotracgeneralonefile_A332655571
gale_infotracacademiconefile_A332655571
gale_incontextgauss_8GL_A332655571
gale_incontextcollege_GICCO_A332655571
pubmed_primary_23349493
pascalfrancis_primary_27485202
crossref_citationtrail_10_2337_db12_0222
crossref_primary_10_2337_db12_0222
PublicationCentury 2000
PublicationDate 2013-06-01
PublicationDateYYYYMMDD 2013-06-01
PublicationDate_xml – month: 06
  year: 2013
  text: 2013-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2013
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Mensah-Brown (2022031210242709100_B12) 2009; 130
Boitard (2022031210242709100_B21) 1981; 21
Iacobini (2022031210242709100_B45) 2004; 18
Mobergslien (2022031210242709100_B36) 2012; 91
Chen (2022031210242709100_B35) 2009; 106
Hsu (2022031210242709100_B10) 2009; 230
Ferraz (2022031210242709100_B34) 2008; 38
Nishimura (2022031210242709100_B3) 2009; 15
Karlsen (2022031210242709100_B18) 2006; 344
Darrow (2022031210242709100_B19) 2011; 43
Lumeng (2022031210242709100_B32) 2007; 117
Lumeng (2022031210242709100_B1) 2011; 121
Ilan (2022031210242709100_B28) 2010; 107
Qiao (2022031210242709100_B41) 2012; 586
Hong (2022031210242709100_B37) 2009; 58
Li (2022031210242709100_B42) 2008; 181
Dinarello (2022031210242709100_B40) 2010; 17
Chan (2022031210242709100_B22) 2005; 96
Sriwijitkamol (2022031210242709100_B6) 2006; 55
Wen (2022031210242709100_B7) 2011; 12
Wentworth (2022031210242709100_B30) 2010; 59
Vandanmagsar (2022031210242709100_B8) 2011; 17
Matthews (2022031210242709100_B20) 1985; 28
Xu (2022031210242709100_B5) 2003; 112
Stienstra (2022031210242709100_B9) 2011; 108
Ohmura (2022031210242709100_B27) 2010; 30
Iacobini (2022031210242709100_B17) 2009; 29
Sakurai (2022031210242709100_B44) 2003; 278
Jiang (2022031210242709100_B11) 2009; 182
Strissel (2022031210242709100_B26) 2010; 18
Saksida (2022031210242709100_B25) 2012
Weisberg (2022031210242709100_B4) 2003; 112
Pugliese (2022031210242709100_B16) 2001; 15
2022031210242709100_B29
Lohmann (2022031210242709100_B24) 2009; 207
Nguyen (2022031210242709100_B31) 2007; 282
Yan (2022031210242709100_B46) 2008; 4
MacKinnon (2022031210242709100_B33) 2008; 180
Schroder (2022031210242709100_B39) 2010; 327
Volarevic (2022031210242709100_B13)
Cani (2022031210242709100_B43) 2008; 57
Feuerer (2022031210242709100_B2) 2009; 15
Radosavljevic (2022031210242709100_B14) 2011; 28
Zhu (2022031210242709100_B15) 2001; 280
Donath (2022031210242709100_B38) 2011; 11
Hall (2022031210242709100_B23) 2008; 123
17200717 - J Clin Invest. 2007 Jan;117(1):175-84
21633179 - J Clin Invest. 2011 Jun;121(6):2111-7
18005036 - Immunology. 2008 Apr;123(4):547-54
12842894 - J Biol Chem. 2003 Sep 19;278(38):36916-23
19633658 - Nat Med. 2009 Aug;15(8):914-20
16600178 - Biochem Biophys Res Commun. 2006 May 26;344(1):406-15
19594632 - Immunol Rev. 2009 Jul;230(1):114-27
21876127 - Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9
20445103 - Proc Natl Acad Sci U S A. 2010 May 25;107(21):9765-70
20111012 - Obesity (Silver Spring). 2010 Oct;18(10):1918-25
18305141 - Diabetes. 2008 Jun;57(6):1470-81
19359660 - Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):831-6
22167721 - J Leukoc Biol. 2012 Mar;91(3):461-7
22213244 - Hepatology. 2012 Jun;55(6):1954-64
15731463 - Circ Res. 2005 Apr 1;96(6):675-83
15361471 - FASEB J. 2004 Nov;18(14):1773-5
20075245 - Science. 2010 Jan 15;327(5963):296-300
7024027 - Diabetologia. 1981 Jul;21(1):41-6
19690064 - Diabetes. 2009 Nov;58(11):2525-35
19706535 - Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14496-501
14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
18250477 - J Immunol. 2008 Feb 15;180(4):2650-8
18684969 - J Immunol. 2008 Aug 15;181(4):2781-9
22569257 - FEBS Lett. 2012 Apr 5;586(7):1022-6
11689472 - FASEB J. 2001 Nov;15(13):2471-9
18332897 - Nat Clin Pract Endocrinol Metab. 2008 May;4(5):285-93
19481752 - Atherosclerosis. 2009 Dec;207(2):360-7
3899825 - Diabetologia. 1985 Jul;28(7):412-9
16505240 - Diabetes. 2006 Mar;55(3):760-7
17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92
11162652 - Biochem Biophys Res Commun. 2001 Feb 2;280(4):1183-8
21478880 - Nat Immunol. 2011 May;12(5):408-15
18845486 - Clin Immunol. 2009 Jan;130(1):83-8
20357360 - Diabetes. 2010 Jul;59(7):1648-56
21442355 - Clin Exp Metastasis. 2011 Jun;28(5):451-62
20636820 - Immunol Rev. 2010 Jul;236:219-42
18825751 - Eur J Immunol. 2008 Oct;38(10):2762-75
14679177 - J Clin Invest. 2003 Dec;112(12):1821-30
21791638 - Physiol Genomics. 2011 Oct 20;43(20):1144-52
22064706 - Immunol Cell Biol. 2012 Aug;90(7):688-98
20588114 - Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):314-21
19910631 - Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):193-9
21217695 - Nat Med. 2011 Feb;17(2):179-88
21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107
19633656 - Nat Med. 2009 Aug;15(8):930-9
19124760 - J Immunol. 2009 Jan 15;182(2):1167-73
References_xml – ident: 2022031210242709100_B29
– volume: 57
  start-page: 1470
  year: 2008
  ident: 2022031210242709100_B43
  article-title: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
  publication-title: Diabetes
  doi: 10.2337/db07-1403
– volume: 59
  start-page: 1648
  year: 2010
  ident: 2022031210242709100_B30
  article-title: Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity
  publication-title: Diabetes
  doi: 10.2337/db09-0287
– volume: 182
  start-page: 1167
  year: 2009
  ident: 2022031210242709100_B11
  article-title: Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.182.2.1167
– volume: 38
  start-page: 2762
  year: 2008
  ident: 2022031210242709100_B34
  article-title: Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200737986
– year: 2012
  ident: 2022031210242709100_B25
  article-title: Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis
  publication-title: Immunol Cell Biol
  doi: 10.1038/icb.2011.89
– volume: 58
  start-page: 2525
  year: 2009
  ident: 2022031210242709100_B37
  article-title: Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle
  publication-title: Diabetes
  doi: 10.2337/db08-1261
– volume: 18
  start-page: 1918
  year: 2010
  ident: 2022031210242709100_B26
  article-title: T-cell recruitment and Th1 polarization in adipose tissue during diet-induced obesity in C57BL/6 mice
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2010.1
– volume: 107
  start-page: 9765
  year: 2010
  ident: 2022031210242709100_B28
  article-title: Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0908771107
– volume: 91
  start-page: 461
  year: 2012
  ident: 2022031210242709100_B36
  article-title: Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.0711361
– volume: 108
  start-page: 15324
  year: 2011
  ident: 2022031210242709100_B9
  article-title: Inflammasome is a central player in the induction of obesity and insulin resistance
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1100255108
– volume: 278
  start-page: 36916
  year: 2003
  ident: 2022031210242709100_B44
  article-title: Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M301598200
– volume: 207
  start-page: 360
  year: 2009
  ident: 2022031210242709100_B24
  article-title: Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2009.05.004
– volume: 18
  start-page: 1773
  year: 2004
  ident: 2022031210242709100_B45
  article-title: Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor
  publication-title: FASEB J
  doi: 10.1096/fj.04-2031fje
– volume: 17
  start-page: 179
  year: 2011
  ident: 2022031210242709100_B8
  article-title: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
  publication-title: Nat Med
  doi: 10.1038/nm.2279
– volume: 180
  start-page: 2650
  year: 2008
  ident: 2022031210242709100_B33
  article-title: Regulation of alternative macrophage activation by galectin-3
  publication-title: J Immunol
  doi: 10.4049/jimmunol.180.4.2650
– volume: 112
  start-page: 1821
  year: 2003
  ident: 2022031210242709100_B5
  article-title: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
  publication-title: J Clin Invest
  doi: 10.1172/JCI200319451
– volume: 4
  start-page: 285
  year: 2008
  ident: 2022031210242709100_B46
  article-title: Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications
  publication-title: Nat Clin Pract Endocrinol Metab
  doi: 10.1038/ncpendmet0786
– volume: 21
  start-page: 41
  year: 1981
  ident: 2022031210242709100_B21
  article-title: Lymphocytes from diabetics suppress insulin release in vitro
  publication-title: Diabetologia
  doi: 10.1007/BF03216222
– volume: 181
  start-page: 2781
  year: 2008
  ident: 2022031210242709100_B42
  article-title: Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.181.4.2781
– volume: 15
  start-page: 914
  year: 2009
  ident: 2022031210242709100_B3
  article-title: CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity
  publication-title: Nat Med
  doi: 10.1038/nm.1964
– volume: 327
  start-page: 296
  year: 2010
  ident: 2022031210242709100_B39
  article-title: The NLRP3 inflammasome: a sensor for metabolic danger?
  publication-title: Science
  doi: 10.1126/science.1184003
– volume: 15
  start-page: 2471
  year: 2001
  ident: 2022031210242709100_B16
  article-title: Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice
  publication-title: FASEB J
  doi: 10.1096/fj.01-0006com
– volume: 11
  start-page: 98
  year: 2011
  ident: 2022031210242709100_B38
  article-title: Type 2 diabetes as an inflammatory disease
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2925
– volume: 230
  start-page: 114
  year: 2009
  ident: 2022031210242709100_B10
  article-title: Galectin-3 regulates T-cell functions
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2009.00798.x
– volume: 117
  start-page: 175
  year: 2007
  ident: 2022031210242709100_B32
  article-title: Obesity induces a phenotypic switch in adipose tissue macrophage polarization
  publication-title: J Clin Invest
  doi: 10.1172/JCI29881
– volume: 28
  start-page: 412
  year: 1985
  ident: 2022031210242709100_B20
  article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
  publication-title: Diabetologia
  doi: 10.1007/BF00280883
– volume: 43
  start-page: 1144
  year: 2011
  ident: 2022031210242709100_B19
  article-title: Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00035.2011
– volume: 344
  start-page: 406
  year: 2006
  ident: 2022031210242709100_B18
  article-title: Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.03.105
– volume: 15
  start-page: 930
  year: 2009
  ident: 2022031210242709100_B2
  article-title: Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
  publication-title: Nat Med
  doi: 10.1038/nm.2002
– volume: 112
  start-page: 1796
  year: 2003
  ident: 2022031210242709100_B4
  article-title: Obesity is associated with macrophage accumulation in adipose tissue
  publication-title: J Clin Invest
  doi: 10.1172/JCI200319246
– volume: 96
  start-page: 675
  year: 2005
  ident: 2022031210242709100_B22
  article-title: Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells
  publication-title: Circ Res
  doi: 10.1161/01.RES.0000160543.84254.f1
– volume: 106
  start-page: 14496
  year: 2009
  ident: 2022031210242709100_B35
  article-title: Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0903497106
– volume: 282
  start-page: 35279
  year: 2007
  ident: 2022031210242709100_B31
  article-title: A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M706762200
– volume: 121
  start-page: 2111
  year: 2011
  ident: 2022031210242709100_B1
  article-title: Inflammatory links between obesity and metabolic disease
  publication-title: J Clin Invest
  doi: 10.1172/JCI57132
– volume: 12
  start-page: 408
  year: 2011
  ident: 2022031210242709100_B7
  article-title: Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
  publication-title: Nat Immunol
  doi: 10.1038/ni.2022
– volume: 130
  start-page: 83
  year: 2009
  ident: 2022031210242709100_B12
  article-title: Targeted disruption of the galectin-3 gene results in decreased susceptibility to multiple low dose streptozotocin-induced diabetes in mice
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2008.08.024
– volume: 586
  start-page: 1022
  year: 2012
  ident: 2022031210242709100_B41
  article-title: TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2012.02.045
– volume: 55
  start-page: 760
  year: 2006
  ident: 2022031210242709100_B6
  article-title: Reduced skeletal muscle inhibitor of kappaB β content is associated with insulin resistance in subjects with type 2 diabetes: reversal by exercise training
  publication-title: Diabetes
  doi: 10.2337/diabetes.55.03.06.db05-0677
– volume: 280
  start-page: 1183
  year: 2001
  ident: 2022031210242709100_B15
  article-title: The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.2001.4256
– volume: 28
  start-page: 451
  year: 2011
  ident: 2022031210242709100_B14
  article-title: Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity
  publication-title: Clin Exp Metastasis
  doi: 10.1007/s10585-011-9383-y
– volume: 17
  start-page: 314
  year: 2010
  ident: 2022031210242709100_B40
  article-title: Role of IL-1β in type 2 diabetes
  publication-title: Curr Opin Endocrinol Diabetes Obes
  doi: 10.1097/MED.0b013e32833bf6dc
– volume: 29
  start-page: 831
  year: 2009
  ident: 2022031210242709100_B17
  article-title: Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.109.186791
– volume: 30
  start-page: 193
  year: 2010
  ident: 2022031210242709100_B27
  article-title: Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.109.198614
– volume: 123
  start-page: 547
  year: 2008
  ident: 2022031210242709100_B23
  article-title: Modulation of diabetes in NOD mice by GAD65-specific monoclonal antibodies is epitope specific and accompanied by anti-idiotypic antibodies
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2007.02724.x
– ident: 2022031210242709100_B13
  article-title: Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice
  publication-title: Hepatology
– reference: 22213244 - Hepatology. 2012 Jun;55(6):1954-64
– reference: 16505240 - Diabetes. 2006 Mar;55(3):760-7
– reference: 18005036 - Immunology. 2008 Apr;123(4):547-54
– reference: 19706535 - Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14496-501
– reference: 14679177 - J Clin Invest. 2003 Dec;112(12):1821-30
– reference: 15731463 - Circ Res. 2005 Apr 1;96(6):675-83
– reference: 19359660 - Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):831-6
– reference: 17916553 - J Biol Chem. 2007 Nov 30;282(48):35279-92
– reference: 21217695 - Nat Med. 2011 Feb;17(2):179-88
– reference: 21876127 - Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15324-9
– reference: 11689472 - FASEB J. 2001 Nov;15(13):2471-9
– reference: 19481752 - Atherosclerosis. 2009 Dec;207(2):360-7
– reference: 22569257 - FEBS Lett. 2012 Apr 5;586(7):1022-6
– reference: 21478880 - Nat Immunol. 2011 May;12(5):408-15
– reference: 21442355 - Clin Exp Metastasis. 2011 Jun;28(5):451-62
– reference: 15361471 - FASEB J. 2004 Nov;18(14):1773-5
– reference: 16600178 - Biochem Biophys Res Commun. 2006 May 26;344(1):406-15
– reference: 20636820 - Immunol Rev. 2010 Jul;236:219-42
– reference: 21233852 - Nat Rev Immunol. 2011 Feb;11(2):98-107
– reference: 22167721 - J Leukoc Biol. 2012 Mar;91(3):461-7
– reference: 19594632 - Immunol Rev. 2009 Jul;230(1):114-27
– reference: 14679176 - J Clin Invest. 2003 Dec;112(12):1796-808
– reference: 12842894 - J Biol Chem. 2003 Sep 19;278(38):36916-23
– reference: 19124760 - J Immunol. 2009 Jan 15;182(2):1167-73
– reference: 18305141 - Diabetes. 2008 Jun;57(6):1470-81
– reference: 19633658 - Nat Med. 2009 Aug;15(8):914-20
– reference: 18332897 - Nat Clin Pract Endocrinol Metab. 2008 May;4(5):285-93
– reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9
– reference: 21633179 - J Clin Invest. 2011 Jun;121(6):2111-7
– reference: 20075245 - Science. 2010 Jan 15;327(5963):296-300
– reference: 20588114 - Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):314-21
– reference: 7024027 - Diabetologia. 1981 Jul;21(1):41-6
– reference: 20445103 - Proc Natl Acad Sci U S A. 2010 May 25;107(21):9765-70
– reference: 20357360 - Diabetes. 2010 Jul;59(7):1648-56
– reference: 17200717 - J Clin Invest. 2007 Jan;117(1):175-84
– reference: 19910631 - Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):193-9
– reference: 18845486 - Clin Immunol. 2009 Jan;130(1):83-8
– reference: 21791638 - Physiol Genomics. 2011 Oct 20;43(20):1144-52
– reference: 18684969 - J Immunol. 2008 Aug 15;181(4):2781-9
– reference: 18825751 - Eur J Immunol. 2008 Oct;38(10):2762-75
– reference: 19633656 - Nat Med. 2009 Aug;15(8):930-9
– reference: 20111012 - Obesity (Silver Spring). 2010 Oct;18(10):1918-25
– reference: 11162652 - Biochem Biophys Res Commun. 2001 Feb 2;280(4):1183-8
– reference: 18250477 - J Immunol. 2008 Feb 15;180(4):2650-8
– reference: 19690064 - Diabetes. 2009 Nov;58(11):2525-35
– reference: 22064706 - Immunol Cell Biol. 2012 Aug;90(7):688-98
SSID ssj0006060
Score 2.480707
Snippet Obesity-induced diabetes is associated with low-grade inflammation in adipose tissue and macrophage infiltration of islets. We show that ablation of galectin-3...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1932
SubjectTerms Ablation
Adipose Tissue - immunology
Adipose Tissue - metabolism
Age
Analysis
Animals
Antibodies
Biological and medical sciences
Blotting, Western
Body fat
Body Weight - genetics
Body Weight - physiology
Cells, Cultured
Cytokines
Diabetes
Diabetes. Impaired glucose tolerance
Diet
Diet, High-Fat - adverse effects
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Flow Cytometry
Galectin 3 - deficiency
Galectin 3 - genetics
Glucose
Homeostasis
Immunohistochemistry
Inflammation
Inflammation - genetics
Inflammation - metabolism
Insulin resistance
Islets of Langerhans - immunology
Islets of Langerhans - metabolism
Lectins
Medical sciences
Metabolic diseases
Metabolism
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Obesity
Obesity - etiology
Obesity - immunology
Obesity - metabolism
Original Research
RNA, Small Interfering
Title Galectin-3 Deficiency Accelerates High-Fat Diet–Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
URI https://www.ncbi.nlm.nih.gov/pubmed/23349493
https://www.proquest.com/docview/1426057003
https://www.proquest.com/docview/1355480146
https://pubmed.ncbi.nlm.nih.gov/PMC3661611
Volume 62
WOSCitedRecordID wos000319845000023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: M7P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Consumer Health Database
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: M0R
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: 7RV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Public Health Database
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: 8C1
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Research Library
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: M2O
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1939-327X
  dateEnd: 20130731
  omitProxy: false
  ssIdentifier: ssj0006060
  issn: 0012-1797
  databaseCode: M2P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYhhAS4vujUCqD0ODFWux8P6HSrQNp7aJpTH2LHH-MSCgtS8ofwF_OXeJ2BE288GIp8i9WnLuc75zz7wh5F-lEQszlQZAjQxbYpGCJkCmzCpwjA526rRJxcRLP58likWZuw612aZUbm9gaar1UuEd-wJFKHcnY_Y-rHwyrRuHfVVdCY4fsgWfDMaVrJrKtJQbnvDuCwgXScMYds5Dw_fhAF5iSIITorUfOKt9byRrekO1KW9zke_6dQvnHmjR98L-zeUjuO2-Ujjv1eURumeoxuTNz_9ufkF_HErf1y4r59NAg2QSe1KRjpWC1QpKJmmKiCJvKhh6WpmFYCUQZTV29ASorTceYtG4hIqdfKgsK2B2WpGVFx7pcLWtDz1vpt-AMXkbrxyoK2mqa-in5Oj06n3xmrmoDU1EcNSxIIm6tp5UfSa8QJgp4oCOeSBB_qjk3oUoLkQZBWGhrbJCC4IqwiHyZSLjB85-R3WpZmReEGqEgWgUF4jGGSTyVNo1MoeCisOAcDsiHjexy5SjNsbLG9xxCGxRzjmLOUcwD8nYLXXU8HjeB9lEBcuTFqDDxRnWbNznMb3Kaj33wdcMwjDmM1gdeynVd58nxSQ_03oHsEp5KSXfgAeaGnFs95H4Pedkxjt8EHPaAYApUr3vU09ztTEUcJKHwYILDjTrmzlbV-bUuDsibbTcOjfl3lVmuAYNuaUs0NCDPO82_HtxvKY7g7rj3TWwByGDe76nKby2TuQ_eYcT5y38_1ityV3RFSJjHh2S3uVqb1-S2-tmU9dWI7MRnF9gu4rZNoE0mfET2Ph3NszO4mnltK07bNsM2zn4D9NVm4w
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELfGQICE-P4olGEQbHuxFjvfDwhVK92qdaUPHdpbcBx7REJpWVIQr_xB_I3cxWlHUMXbHniM_ItlO3fnO-f8O0JeB1kkIeZyIMiRPvNMlLJIyJgZBc6RhsasrhLxcRSOx9HpaTzZIL-Wd2EwrXJpE2tDnc0UnpHvcaRSRzJ29938K8OqUfh3dVlCw4rFkf7xHUK28u2wD9_3jRCD99P9Q9ZUFWAqCIOKeVHAjXEy5QbSSYUOPO5lAY8kDC_OONe-ilMRe56fZkYbL4Y9MfXTwJWRhBccF_q9Qq56yCyGqYJisrL8EAzYKy9cIO1naJmMhOuGe1mKKRBCiNb-1-wCt-ayhC9ibCmNdb7u3ymbf-yBgzv_2-rdJbcbb5v2rHrcIxu6uE-uHzf5BA_IzwOJvy3ygrm0r5FMA2-i0p5SsBsjiUZJMRGGDWRF-7muGFY6UTqjTT0FKouM9jAp3-SAHRYGFMxeBqV5QXtZPp-Vmk5r6a7BE1j82k9XFLRRV-VDcnIpK_CIbBazQj8hVAsF0TgoCA8xDOSxNHGgUwUPqQHnt0N2l7KSqIayHSuHfEkgdEOxSlCsEhSrDnm1gs4tT8k60DYKXIK8HwUmFil7OJXA_PY_JD0XfHnf90MOvbWBZ3JRlkl0MGqBdhqQmcGolGwudMDckFOshdxuIc8so_o6YLcFBFOnWs1bLU1ZzVSEXuQLBybYXYp_0tjiMrmQ_Q55uWrGrjG_sNCzBWDQ7a6JlDrksdW0i87dmsIJ3g5bOrgCIEN7u6XIP9dM7S54vwHnT_89rBfkxuH0eJSMhuOjZ-SmsAVXmMO7ZLM6X-jn5Jr6VuXl-VZtbij5dNka-hsjULx7
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELfGQBMS4nNAoQyDYPBiNXa-HxCqVjqqdaVCG9pb5vhjREJpWVIQr_xZ_HXcJWlHUMXbHniM_Itlx3e-O-f8O0JeBDqSEHM5EORIn3k2SlkkZMysAufIQKOuqkR8GoeTSXRyEk83yK_lXRhMq1zuidVGrWcKz8h7HKnUkYzd7dkmLWI6GL6df2VYQQr_tC7LadQicmB-fIfwrXgzGsBavxRi-O5o7z1rKgwwFYRBybwo4NY6WrmBdFJhAo97OuCRhKHGmnPjqzgVsef5qbbGejHYx9RPA1dGEl5wXOj3Crkaer5A3v5D5-PKCkBgUF9_4QIpQMOa1Ui4btjTKaZDCCFatrCxCDfmsoDVsXVZjXV-79_pm3_Yw-Gt__lL3iY3Gy-c9mu1uUM2TH6XbB02eQb3yM99ib8zspy5dGCQZANvqNK-UmClkVyjoJggw4aypIPMlAwroCijaVNngcpc0z4m69sMsKPcguLVl0RpltO-zuazwtCjSuor8BQWovLfFQUtNWWxTY4v5QvcJ5v5LDcPCTVCQZQOisNDDA95LG0cmFTBQ2rBKe6Q10u5SVRD5Y4VRb4kENKhiCUoYgmKWIc8X0HnNX_JOtAuCl-CfCA5yoOqD60SmN_eh6Tvgo_v-37Iobc28EwuiiKJ9sct0KsGZGcwKiWbix4wN-QaayF3W8izmml9HbDbAsIWqFrNOy2tWc1UhF7kCwcm2F2qQtLs0UVyoQcd8mzVjF1j3mFuZgvAoDteESx1yINa6y46dytqJ3g7bOnjCoDM7e2WPPtcMbi74BUHnD_697Ceki1QzGQ8mhw8JtdFXYeFObxLNsvzhXlCrqlvZVac71Q7DyWnl62gvwECxcU-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Galectin-3+Deficiency+Accelerates+High-Fat+Diet%E2%80%93Induced+Obesity+and+Amplifies+Inflammation+in+Adipose+Tissue+and+Pancreatic+Islets&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Pejnovic%2C+Nada+N.&rft.au=Pantic%2C+Jelena+M.&rft.au=Jovanovic%2C+Ivan+P.&rft.au=Radosavljevic%2C+Gordana+D.&rft.date=2013-06-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=62&rft.issue=6&rft.spage=1932&rft.epage=1944&rft_id=info:doi/10.2337%2Fdb12-0222&rft_id=info%3Apmid%2F23349493&rft.externalDocID=PMC3661611
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon